Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Borderline Personality Disorder01:25

Borderline Personality Disorder

Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis.

Early intervention in psychiatry·2026
Same author

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Impacted and preserved sub-domains of cognitive control in schizophrenia.

Neuropsychologia·2026
Same author

Persistent Negative Symptoms: Characterization of an Unmet Need in a Learning Health System for First-Episode Psychosis.

Schizophrenia bulletin·2026
Same author

The Biological Psychiatry Family of Journals Is Rewarding Its Reviewers.

Biological psychiatry·2026
Same author

Prior Trial Effects on Working Memory in Schizophrenia, Bipolar Disorder, and Healthy Control Individuals.

JAMA psychiatry·2026
Same journal

Enhancing Affective Cognitive Control in Bipolar Disorder Using Transcranial Alternating Current Stimulation: A Double-Blind, Randomized, Sham-Controlled Clinical Trial and Proof of Concept Study.

Bipolar disorders·2026
Same journal

Psychotropic Prescribing Patterns Among Bipolar-I Patients Prior to Established Bipolar-I Disorder Diagnosis.

Bipolar disorders·2026
Same journal

Speech and Language Markers of Bipolar Disorder: Challenges and Opportunities.

Bipolar disorders·2026
Same journal

Can We Improve the Prediction of Early Onset Mania and Hypomania in the Community?

Bipolar disorders·2026
Same journal

How Do Parents With Bipolar Disorder Perceive the Risk to the Next Generation? Results From a Qualitative Study.

Bipolar disorders·2026
Same journal

Cross-Sectional and Longitudinal Comparison of Commonly Used Screening Tools for Bipolar Disorders.

Bipolar disorders·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

Bipolar Disorder Psychosis Risk Predicts Cue Discrimination on the AX-Continuous Performance Task Paradigm.

Meghan Fiske1, Dominique L DiDomenico1, Henry W Chase1

  • 1Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Bipolar Disorders
|June 9, 2026
PubMed
Summary
This summary is machine-generated.

Sustained attention deficits in Bipolar Disorder (BD) are linked to psychosis and mania risk, not the diagnosis itself. These findings suggest dimensional models may better explain attention impairments in BD and at-risk individuals.

Keywords:
AX‐CPTbipolar disordermania affective labilitypsychosissustained attention

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Bipolar Disorder (BD) is characterized by mania, affective lability, and psychosis risk, often accompanied by sustained attention deficits.
  • The AX-Continuous Performance Test (AX-CPT) reliably identifies impairments in schizophrenia-spectrum psychosis, but its utility in BD is debated.
  • Understanding cognitive deficits in BD is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the association between individual differences in mania/affective lability risk and psychosis risk with AX-CPT performance in BD and at-risk individuals.
  • To determine if these risks are associated with specific AX-CPT measures (d'context and A-cue bias).

Main Methods:

  • The study utilized the AX-Continuous Performance Test (AX-CPT) to measure sustained attention.
  • Standard measures d'context and A-cue bias quantified AX-CPT performance.
  • The Mood Spectrum Self Report (MOODS-SR-L) assessed lifetime mania/affective lability and psychosis risk.
  • Linear regressions and ANCOVAs were employed to analyze the data.

Main Results:

  • Higher psychosis and mania/affective lability risk were associated with reduced target discrimination (d'context) in euthymic BD and at-risk individuals.
  • No significant association was found with A-cue bias.
  • These associations remained after controlling for depressive symptoms but were attenuated by current mania severity.

Conclusions:

  • Target discrimination deficits in BD are dimensionally associated with psychosis and mania/affective lability risk, rather than being solely a categorical feature of the BD diagnosis.
  • Dimensional risk models offer a promising framework for understanding sustained attention deficits in BD.
  • The findings underscore the importance of considering mania/affective lability and psychosis risk in cognitive assessments of BD.